SOM DATT FINANCE CORPORATION LTD.

Crescentis Capital Ltd (formerly Som Datt Finance Corporation Limited) has announced a Board of Directors meeting scheduled for November 12, 2026. The primary agenda is to consider, approve, and take on record the Unaudited Financial Results for the Second Quarter and Half-Year ended September 30, 2026, along with the Limited Review Report. The trading window for securities, which closed on October 1, 2026, will reopen 48 hours after the declaration of these financial results.

Crescentis Capital Ltd (formerly Som Datt Finance Corporation Limited) announced that its Board of Directors has approved the Letter of Offer for a Rights Issue. The issue involves offering 1,02,08,129 fully paid-up equity shares of face value ₹10 each at a price of ₹78 per share, aggregating to ₹7,962.34 Lakhs (₹79.62 Crore). This is on a rights basis to eligible equity shareholders in the ratio of 3 shares for every 5 shares held as of the record date, November 4, 2026. The company also confirmed that none of its promoters or directors are wilful defaulters or fraudulent borrowers.

Crescentis Capital Ltd (formerly Som Datt Finance Corporation Limited) announced that its Board of Directors has approved the Letter of Offer, Composite Application Form, and Rights Entitlement letter for a Rights issue. The issue involves offering 1,02,08,129 fully paid-up equity shares of face value ₹10 each at a price of ₹78 per share, aggregating to ₹7,962.34 Lakhs (₹79.62 Crore), on a rights basis. This is in the ratio of 3 equity shares for every 5 fully paid-up equity shares held as of the record date, November 4, 2026. The company also provided historical information regarding its incorporation, name change, and registered office shifts.

Crescentis Capital Ltd has announced that its Board of Directors will convene on November 3, 2026. The primary agenda item is to consider and approve the Letter of Offer, Composite Application Form, and Rights Entitlement letter for an upcoming rights issue of equity shares. This follows BSE's in-principle approval for the listing of these shares, granted via a letter dated October 23, 2026. The meeting notice is issued in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Crescentis Capital Ltd has announced a Board of Directors meeting scheduled for November 3, 2026. The primary agenda is to consider and approve the terms and conditions for a proposed Rights Issue of equity shares, including issue price, size, and record date. This follows the Board's earlier approval on September 30, 2026, to raise up to ₹80 crores through this rights issue. The meeting will also approve the Letter of Offer, Composite Application Form, and Rights Entitlement letter. The company has received in-principle approval from BSE for the listing of these shares. Separately, the trading window for designated persons has been closed since October 1, 2026, for the consideration of unaudited financial results for the quarter and half-year ending September 30, 2026.

Crescentis Capital Ltd's Fund Raising Committee has fixed November 4, 2026, as the record date to determine equity shareholders eligible for the upcoming Rights Issue. This decision was made during the committee's meeting on October 29, 2026, in compliance with SEBI LODR Regulations and SEBI (ICDR) Regulations, 2018. The company had previously received in-principle approval from BSE Limited for the listing of shares to be issued on a rights basis.

Crescentis Capital Ltd's Fund Raising Committee has approved the terms for a Rights Issue. The company will issue 1,02,08,129 Rights Equity Shares at ₹78 each, aggregating up to ₹79,62,34,062/- (assuming full subscription). The issue price includes a premium of ₹68 per share. The record date is set for Wednesday, November 4, 2026. The Rights Issue will open on Monday, November 16, 2026, and close on Friday, November 27, 2026. Shareholders will be entitled to 3 Equity Shares for every 5 Equity Shares held on the record date. Post-rights issue, the total equity shares will increase to 2,72,21,678 from the current 1,70,13,549.

Crescentis Capital Ltd has announced a meeting of its Fund-Raising Committee of the Board of Directors on October 29, 2026. The meeting will consider and approve the terms of a proposed Rights Issue of equity shares, aiming to raise up to ₹80 crores. This follows the Board's approval on September 30, 2026, for the rights issue. The committee will also take on record the BSE's in-principle approval for listing the shares. The trading window for designated persons remains closed until further notice.

Crescentis Capital Ltd has determined October 8, 2026, as the grant date for Employee Stock Options (ESOPs) to its Managing Director, Mr. Subba Rao Veeravenkata Meka. This grant, under the CCL ESOS 2025, involves 5,00,000 stock options at an exercise price of ₹50 per option. The options will vest in two tranches: 50% on October 7, 2027, and the remaining 50% on October 7, 2028. This action follows shareholder approval at the 33rd AGM and is in compliance with SEBI regulations.

Crescentis Capital Ltd (formerly Som Datt Finance Corporation Limited) has announced a proposed Rights Issue to raise up to ₹80 crores. The company plans to issue equity shares of face value ₹10 each at a premium, with the aggregate amount including premium not exceeding ₹80 crores. This move is in accordance with applicable laws and regulations, including the SEBI ICDR Regulations, and is subject to necessary approvals. The Draft Letter of Offer has been filed, detailing the terms and conditions of the issue, including the ratio of rights shares to existing shares and the record date, which are yet to be specified. The company also provided its updated CIN and registered office details in Telangana.